CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 59 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | -44.1% | 28,254 | 0.0% | 0.00% | – |
| Q2 2023 | $34 | +3.0% | 28,254 | 0.0% | 0.00% | – |
| Q1 2023 | $33 | +50.0% | 28,254 | 0.0% | 0.00% | – |
| Q4 2022 | $22 | -99.9% | 28,254 | +0.7% | 0.00% | – |
| Q3 2022 | $33,000 | +32.0% | 28,054 | 0.0% | 0.00% | – |
| Q2 2022 | $25,000 | -50.0% | 28,054 | 0.0% | 0.00% | – |
| Q1 2022 | $50,000 | +16.3% | 28,054 | -1.0% | 0.00% | – |
| Q4 2021 | $43,000 | -37.7% | 28,339 | -17.4% | 0.00% | – |
| Q3 2021 | $69,000 | – | 34,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 193,715 | $347,000 | 0.10% |
| Wealth Advisory Solutions, LLC | 156,850 | $281,000 | 0.06% |
| Horst & Graben Wealth Management LLC | 75,722 | $136,000 | 0.03% |
| Miller Investment Management, LP | 50,000 | $90,000 | 0.01% |
| Cutler Group LLC / CA | 291,300 | $112,000 | 0.01% |
| Syverson Strege & Co | 2,145 | $4,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $308,000 | 0.00% |
| HighTower Advisors, LLC | 217,623 | $389,000 | 0.00% |
| Kestra Advisory Services, LLC | 40,137 | $72,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,272,145 | $4,067,000 | 0.00% |